AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

FUROSEMIDE BP

9 registrations across 5 African markets— 4 active

Markets with FUROSEMIDE BP

Recent registrations

Brand / ProductMarketHolderStatusExpires
Furosemide tablets
Tablet Uncoated
🇿🇲ZambiaINTERMAC LIMITEDactiveMay 2030
UNOSEMIDE 10
Injection
🇷🇼RwandaAKUMS DRUGS & PHARMACEUTICALS LTDactiveFeb 2030
AGOMIDE TABLET
TABLETS
🇷🇼RwandaAGOG PHARMA LTDactiveJul 2029
FUROSEMIDE TABLETS
Tablet
🇰🇪KenyaCOSMOS LIMITEDactiveMay 2029
BAKAN GIZO FUROSEMIDE TABLETS
TABLETS
🇳🇬NigeriaBAKAN GIZO NIG. LTD B13expiredFeb 2023
TAMAR & PHAREZ FUROSEMIDE TABLETS
TABLETS/10X10
🇳🇬NigeriaTAMAR & PHAREZ PHARM LTD 2expiredApr 2021
FUROSEMIDE 10MG/ML INJECTION
INJECTION
🇲🇼MalawiexpiredJun 2008
FUROSEMIDE 40MG TABLET
TABLET
🇲🇼MalawiexpiredJun 2008
FUROSEMIDE 40MG TABLET
TABLET
🇲🇼MalawiexpiredJun 2007

FUROSEMIDE BP in Africa — Regulatory Overview

FUROSEMIDE BP is registered across 5 African markets with 9 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Malawi, Nigeria, Rwanda, Kenya and 1 more. AfricaRegulatory refreshes this data daily from official government sources.

Of the 9 registrations, 4 (44%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.